Abeona Therapeutics (NASDAQ:ABEO) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate of $(0.35) by 14.29 percent. This is a 25 percent decrease over losses of $(0.24) per share from the same period last year. The company reported quarterly sales of $8.720 million which beat the analyst consensus estimate of $4.572 million by 90.74 percent.